These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 28702715)

  • 1. [The EU Portal: Implementation, importance, and features].
    von Aschen H; Krafft H
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Aug; 60(8):812-816. PubMed ID: 28702715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Implementation status of Regulation EU 536/2014 in the member states].
    Stahl E
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Aug; 60(8):836-840. PubMed ID: 28638933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Principles of the EU Clinical Trials Regulation No 536/2014 : What will change?].
    Mende A; Frech M; Riedel C
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Aug; 60(8):795-803. PubMed ID: 28685215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strengthening and rationalizing pharmacovigilance in the EU: where is Europe heading to? A review of the new EU legislation on pharmacovigilance.
    Borg JJ; Aislaitner G; Pirozynski M; Mifsud S
    Drug Saf; 2011 Mar; 34(3):187-97. PubMed ID: 21332243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Approval of clinical trials with biological medicinal products].
    Gross S; Jost N; Hartmann JP
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Aug; 60(8):826-829. PubMed ID: 28677049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Changes in the German Medicinal Product Act imposed by the EU regulation on clinical trials].
    Nickel L; Seibel Y; Frech M; Sudhop T
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Aug; 60(8):804-811. PubMed ID: 28664271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delays in completion and results reporting of clinical trials under the Paediatric Regulation in the European Union: A cohort study.
    Hwang TJ; Tomasi PA; Bourgeois FT
    PLoS Med; 2018 Mar; 15(3):e1002520. PubMed ID: 29494592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [First experiences with the implementation of EU Regulation 536/2014 (CTR) from the perspective of non-commercial academic research].
    Fuhrmann C; Reineke C; Lang B; Grählert X
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2023 Jan; 66(1):38-44. PubMed ID: 36525036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The new approval procedure for clinical trials of medicinal products in the European Union-challenges for the pharmaceutical industry in Germany].
    Henn DK; Ruppert T
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2023 Jan; 66(1):28-37. PubMed ID: 36449064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical trials in Germany and in the EU in the new legislative environment. An analysis from the industry's point of view].
    Heidenreich K; Möritz A; Löffler H; Oberle-Rolle B
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 Apr; 48(4):415-22. PubMed ID: 15830252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical trials with investigational medicinal products-initial experiences with the new EU clinical trial regulation 536/2014 and challenges and opportunities for contract research organisations].
    Chase D; Roder B; Romero Matuschek I
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2023 Jan; 66(1):21-27. PubMed ID: 36525037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Public information on shortages in the EU/EEA: improvements made between 2018 and 2020.
    Abed I; Garcia Burgos J; Knudsen Y
    Eur J Hosp Pharm; 2024 Jun; 31(4):344-347. PubMed ID: 36754622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Granting marketing authorisation for medicines in South East European countries: the point of view of the authority.
    Tomić S; Sucić AF; Martinac AI
    Regul Toxicol Pharmacol; 2010; 57(2-3):325-32. PubMed ID: 20385190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pediatric investigation plans for specific immunotherapy: Questionable contributions to childhood health.
    Rose K; Kopp MV
    Pediatr Allergy Immunol; 2015 Dec; 26(8):695-701. PubMed ID: 26495999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The impact of the EU Regulation 536/2014 on the tasks and functioning of ethics committees in Germany].
    Hasford J
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Aug; 60(8):830-835. PubMed ID: 28638934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Joint pilot project of the German higher federal authorities and ethics committees on implementing the EU Regulation on clinical trials].
    Sudhop T; Grass G; Wessler I
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Aug; 60(8):817-825. PubMed ID: 28664274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [More transparency in clinical research: How are the new transparency regulations assessed from the perspective of the pharmaceutical industry?].
    Wachenhausen H; Peters J
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2023 Jan; 66(1):60-67. PubMed ID: 36542105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New legal requirements for submission of product information to poisons centres in EU member states.
    de Groot R; Brekelmans P; Desel H; de Vries I
    Clin Toxicol (Phila); 2018 Jan; 56(1):1-6. PubMed ID: 28644742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-risk trials for children and pregnant women threatened by unnecessary strict regulations. Does the coming EU Clinical Trial Regulation offer a solution?
    Knaapen M; Ploem MC; Kruijt M; Oudijk MA; van der Graaf R; Bet PM; Bakx R; van Heurn LWE; Gorter RR; van der Lee JH
    Eur J Pediatr; 2020 Aug; 179(8):1205-1211. PubMed ID: 32535715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The European clinical trials regulation (No 536/2014): changes and challenges.
    Scavone C; di Mauro G; Pietropaolo M; Alfano R; Berrino L; Rossi F; Tomino C; Capuano A
    Expert Rev Clin Pharmacol; 2019 Nov; 12(11):1027-1032. PubMed ID: 31608706
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.